EAU22 game-changing session webcast “Overall Survival With Darolutamide Versus Placebo in Combination With Androgen-deprivation Therapy and Docetaxel by Stratification Factors in the Phase 3 ARASENS Trial” by Prof. Tombal.
Watch the Discussant by Dr. Radtke here.